Back to search
FDAFDA · Food and drugs·Recall number D-0106-2027

OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50

Published November 4, 2026 · Recall initiated: October 8, 2026

Summary

FDA records drug Class II recall D-0106-2027, published November 4, 2026 and initiated October 8, 2026. Recalling firm: Eagle Pharma Outsourcing LLC; Status: Ongoing; Reported quantity: 5 500-mL containers; Lot: Lot: OXY30-1006, Expiry: 10/10/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Eagle Pharma Outsourcing LLC
Distributor
Nationwide within the U.S
Lot
Lot: OXY30-1006, Expiry: 10/10/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50 recalled?

Yes. FDA published recall D-0106-2027 on November 4, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail